On September 10, the United States Environmental Protection Agency (EPA) issued a directive to aggressively prioritize reductions in animal testing towards a 30% decrease in such tests by 2025, and complete elimination of requests by the EPA for animal studies by 2035. In a companion memo by EPA Administrator Andrew Wheeler, the EPA also announced...
Limiting access to food in mice increases levels of the hormone, ghrelin, which may also increase motivation to exercise, according to a study published in the Journal of Endocrinology. The study suggests that a surge in levels of appetite-promoting hormone, ghrelin, after a period of fasting prompted mice to initiate voluntary exercise. These novel findings...
As part of the Endocrine Society’s commitment to improving public health by reducing exposure to endocrine-disrupting chemicals (EDCs), our members work with international organizations and participate in many international meetings to provide advice and guidance to regulators and policymakers worldwide. One example is the Organization for Economic Cooperation and Development (OECD), which has worked since...
Last night, the Centers for Medicare and Medicaid Services (CMS) announced its proposed 2020 Physician Fee Schedule rule, which will change payment policies under the physician fee schedule and other Part B payment policies. We are pleased to announce that CMS decided not to finalize several changes introduced in its 2019 rule for 2021 payment...
Here is a quick run down of major issues being discussed by policymakers from an endocrine perspective and the Society’s current advocacy work. Let us know if you would like additional information or have any questions. What’s Happening in Washington & What We Are Working On Congress returned from a week-long district work period and...
The Endocrine Society is a leading advocate on several issues that would increase access to diabetes coverage and funding for important research. See below for recent highlights of our activities concerning the reauthorization of the Special Diabetes Program, insulin affordability, and diabetes testing supplies. Special Diabetes Program – Ensuring continuation of the Special Diabetes Program...
Here is a quick run down of major issues being discussed by policymakers from an endocrine perspective and the Society’s current advocacy work. Let us know if you would like additional information or have any questions. What’s Happening in Washington Appropriations & NIH Funding: Good News/Bad News—This week House Appropriations Committee reported out the Labor-HHS...
Here is a quick run down of major issues being discussed by policymakers from an endocrine perspective and the Society’s current advocacy work. Let us know if you would like additional information or have any questions. What’s Happening in Washington Health care headlines dominated Capitol Hill this week, thanks to a hearing on the progressive...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.